2nd Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$775,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

No bill, trade agreements and international intelectual property issues in India and Canada related to biopharmaceuticals. H.R. 3830 amnd S. 1900, Biaprtisan Congressional Trade Priorities Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: S. 1900 (113th), H.R. 3830 (113th)

Taxation/Internal Revenue Code TAX

H.R. 3474, Tax Extenders legislations, regarding all biopharmaceutical related provisions. H.R. 4438, American Research and Investment Act, regarding all biopharmceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Bills named: H.R. 4438 (113th), H.R. 3474 (113th)

Copyright/Patent/Trademark CPT

H.R. 3309, S. 1720, and S. 1612, S. 1013, S. 866, legislation to amend certain patent laws. Regarding all provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Bills named: S. 1013 (113th), S. 1720 (113th), S. 866 (113th), H.R. 3309 (113th), S. 1612 (113th)

Health Issues HCR

H.J. Res 59, Continuing Appropriations Resolution, regarding all biopharmaceutical related provisions. Labor, HHS Appropriations, regarding all biopharmaceutical related provisons. Agriculture approrpiations, regarding all biopharmceutical related provisions.H.R. 2725/S. 1413, FDA Safety over Sequestration Act, regarding all biopharmaceutical user-fees. No-bill, edcuational meetings regarding atrial fibrilation. No bill - regarding FDA regulatory issues and patent incentives related to the 21st Century Cures Initiative. Health Care Reform implementation - regarding essential health benefits coverage and all biopharmaceutical related provisions. H.R. 3723, Viral Hepatitis Testing Act, regarding all provisions.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1413 (113th), H.R. 2725 (113th), H.R. 3723 (113th), H.J.Res. 59 (113th)

Medicare/Medicaid MMM

H.R. 1325 S. 323, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" regarding all provsions. H.R. 1416, "Cancer Patient Protection Act of 2013," regarding all provisions. H.R. 351 and S. 351, "Protecting Seniors' Access to Medicare Act of 2013," regarding all provisions. H.R. 2010 an dS. 1821, SGR Reform, regarding all provisions.H.R. 4301, Protecting Access to Medicare act, regarding all provisions.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: S. 323 (113th), H.R. 351 (113th), H.R. 1416 (113th), H.R. 4301 (113th), H.R. 1325 (113th), S. 351 (113th), H.R. 2010 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.